Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus

Objectives– To examine the expression of OX40, an activated memory T‐cell marker, and its ligand (OX40L), a set of molecules for T‐cell–B‐cell interaction, and other lymphocyte activation markers in the thymuses of myasthenia gravis (MG) and controls. Material and methods– We studied the expression...

Full description

Saved in:
Bibliographic Details
Published inActa neurologica Scandinavica Vol. 102; no. 4; pp. 236 - 243
Main Authors Onodera, J., Nagata, T., Fujihara, K., Ohuchi, M., Ishii, N., Sugamura, K., Itoyama, Y.
Format Journal Article
LanguageEnglish
Published Copenhagen Munksgaard International Publishers 01.10.2000
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives– To examine the expression of OX40, an activated memory T‐cell marker, and its ligand (OX40L), a set of molecules for T‐cell–B‐cell interaction, and other lymphocyte activation markers in the thymuses of myasthenia gravis (MG) and controls. Material and methods– We studied the expression of OX40, OX40L, IL‐2Rα and HLA‐DR in the thymic tissues of MG and controls using immunocytochemistry and flowcytometry. Results– In both hyperplastic thymus of MG and control thymus, OX40+ cells were scattered mainly in the medulla with much fewer OX40L+ cells being distributed in the corticomedullary junctions. IL‐2Rα and HLA‐DR were expressed in the medulla at higher frequencies as compared with OX40 in controls as well as MG. In contrast, the numbers of OX40+ cells around the germinal centers (GC) were significantly greater than those of control thymuses, and some mononuclear cells in GC were OX40L+. A considerable number of OX40+ cells were seen in the thymic tissues adjacent to thymomas. OX40+ cells were CD4+CD8− or CD4+CD8+ and were mostly HLA‐DR−. (The coexpression of OX40 and IL‐2Rα on activated CD4+ T cells was previously reported.) Conclusion– OX40, expressed in a fraction of activated CD4+ T cells, may be upregulated in thymic tissues adjacent to GC and thymoma in MG, and OX40 may interact with OX40L in GC to enhance anti‐acetylcholine receptor antibody production in MG.
AbstractList OBJECTIVESTo examine the expression of OX40, an activated memory T-cell marker, and its ligand (OX40L), a set of molecules for T-cell-B-cell interaction, and other lymphocyte activation markers in the thymuses of myasthenia gravis (MG) and controls. MATERIAL AND METHODSWe studied the expression of OX40, OX40L, IL-2Ralpha and HLA-DR in the thymic tissues of MG and controls using immunocytochemistry and flowcytometry. RESULTSIn both hyperplastic thymus of MG and control thymus, OX40+ cells were scattered mainly in the medulla with much fewer OX40L+ cells being distributed in the corticomedullary junctions. IL-2Ralpha and HLA-DR were expressed in the medulla at higher frequencies as compared with OX40 in controls as well as MG. In contrast, the numbers of OX40+ cells around the germinal centers (GC) were significantly greater than those of control thymuses, and some mononuclear cells in GC were OX40L+. A considerable number of OX40+ cells were seen in the thymic tissues adjacent to thymomas. OX40+ cells were CD4+ CD8- or CD4+ CD8+ and were mostly HLA-DR-. (The coexpression of OX40 and IL-2Ralpha on activated CD4+ T cells was previously reported.) CONCLUSIONOX40, expressed in a fraction of activated CD4+ T cells, may be upregulated in thymic tissues adjacent to GC and thymoma in MG, and OX40 may interact with OX40L in GC to enhance anti-acetylcholine receptor antibody production in MG.
Objectives– To examine the expression of OX40, an activated memory T‐cell marker, and its ligand (OX40L), a set of molecules for T‐cell–B‐cell interaction, and other lymphocyte activation markers in the thymuses of myasthenia gravis (MG) and controls. Material and methods– We studied the expression of OX40, OX40L, IL‐2Rα and HLA‐DR in the thymic tissues of MG and controls using immunocytochemistry and flowcytometry. Results– In both hyperplastic thymus of MG and control thymus, OX40+ cells were scattered mainly in the medulla with much fewer OX40L+ cells being distributed in the corticomedullary junctions. IL‐2Rα and HLA‐DR were expressed in the medulla at higher frequencies as compared with OX40 in controls as well as MG. In contrast, the numbers of OX40+ cells around the germinal centers (GC) were significantly greater than those of control thymuses, and some mononuclear cells in GC were OX40L+. A considerable number of OX40+ cells were seen in the thymic tissues adjacent to thymomas. OX40+ cells were CD4+CD8− or CD4+CD8+ and were mostly HLA‐DR−. (The coexpression of OX40 and IL‐2Rα on activated CD4+ T cells was previously reported.) Conclusion– OX40, expressed in a fraction of activated CD4+ T cells, may be upregulated in thymic tissues adjacent to GC and thymoma in MG, and OX40 may interact with OX40L in GC to enhance anti‐acetylcholine receptor antibody production in MG.
To examine the expression of OX40, an activated memory T-cell marker, and its ligand (OX40L), a set of molecules for T-cell-B-cell interaction, and other lymphocyte activation markers in the thymuses of myasthenia gravis (MG) and controls. We studied the expression of OX40, OX40L, IL-2Ralpha and HLA-DR in the thymic tissues of MG and controls using immunocytochemistry and flowcytometry. In both hyperplastic thymus of MG and control thymus, OX40+ cells were scattered mainly in the medulla with much fewer OX40L+ cells being distributed in the corticomedullary junctions. IL-2Ralpha and HLA-DR were expressed in the medulla at higher frequencies as compared with OX40 in controls as well as MG. In contrast, the numbers of OX40+ cells around the germinal centers (GC) were significantly greater than those of control thymuses, and some mononuclear cells in GC were OX40L+. A considerable number of OX40+ cells were seen in the thymic tissues adjacent to thymomas. OX40+ cells were CD4+ CD8- or CD4+ CD8+ and were mostly HLA-DR-. (The coexpression of OX40 and IL-2Ralpha on activated CD4+ T cells was previously reported.) OX40, expressed in a fraction of activated CD4+ T cells, may be upregulated in thymic tissues adjacent to GC and thymoma in MG, and OX40 may interact with OX40L in GC to enhance anti-acetylcholine receptor antibody production in MG.
Author Fujihara, K.
Ohuchi, M.
Onodera, J.
Nagata, T.
Ishii, N.
Itoyama, Y.
Sugamura, K.
Author_xml – sequence: 1
  givenname: J.
  surname: Onodera
  fullname: Onodera, J.
  organization: Departments of Neurology, and
– sequence: 2
  givenname: T.
  surname: Nagata
  fullname: Nagata, T.
  organization: Departments of Neurology, and
– sequence: 3
  givenname: K.
  surname: Fujihara
  fullname: Fujihara, K.
  organization: Departments of Neurology, and
– sequence: 4
  givenname: M.
  surname: Ohuchi
  fullname: Ohuchi, M.
  organization: Division of Thoracic and Cardiovascular Surgery, Sendai National Hospital, Sendai, Japan
– sequence: 5
  givenname: N.
  surname: Ishii
  fullname: Ishii, N.
  organization: Microbiology and Immunology, Tohoku University School of Medicine
– sequence: 6
  givenname: K.
  surname: Sugamura
  fullname: Sugamura, K.
  organization: Microbiology and Immunology, Tohoku University School of Medicine
– sequence: 7
  givenname: Y.
  surname: Itoyama
  fullname: Itoyama, Y.
  organization: Departments of Neurology, and
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1493744$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11071109$$D View this record in MEDLINE/PubMed
BookMark eNpFkUtPAjEUhRuDkYf-BTMLY3Qx2E7vPLpEwsMEIRoN7prS6WhxpoNTiPDv7QjiormP8-WkObeNGqY0CqErgrsEU7hbdkmEsY8BQzfAuN66AgGNutsT1DqKDdRyKvEjSqCJ2tYu3RTEAGeoSQiO3WMt9DjYriplrS6NV2be7A2wJ0y6b3L9Xvc37ysKt5423vpDeaasCpH_QsVOWLcyWjplV2zsOTrNRG7VxaF20Otw8NIf-5PZ6KHfm_gSQhz5UuGEARUYEiUjCGImMsrCNEiplGkGKoyTLFsAiDCRkhJKFGOi_ntEWcQWtIOu976rqvzaKLvmhbZS5bkwqtxYHgeUORo78PIAbhaFSvmq0oWodvwvAAdcHQBhpcizShip7T8HjDojhw332LfO1e5fxry-CV_yOnZex87rm_DjTfiW96aD4-iM_L2Rtmu1PRqJ6pNHMY1DPp-O-FMS3s-fkzEP6A9YUI26
CODEN ANRSAS
CitedBy_id crossref_primary_10_1111_j_1365_2249_2005_02955_x
crossref_primary_10_1155_2022_4337399
crossref_primary_10_4049_jimmunol_169_8_4628
crossref_primary_10_1073_pnas_0402654101
crossref_primary_10_4049_jimmunol_172_6_3580
crossref_primary_10_1016_S0022_510X_01_00668_2
crossref_primary_10_1007_s12016_015_8498_3
ContentType Journal Article
Copyright 2000 INIST-CNRS
Copyright_xml – notice: 2000 INIST-CNRS
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1034/j.1600-0404.2000.102004236.x
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0404
EndPage 243
ExternalDocumentID 11071109
1493744
ANE102004236
ark_67375_WNG_Q85BWR8H_2
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAKAS
AAONW
AASGY
AAVGM
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABHUG
ABIVO
ABJNI
ABLJU
ABPTK
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEQTP
AEUQT
AFBPY
AFEBI
AFFNX
AFGKR
AFKRA
AFPWT
AFVGU
AFZJQ
AGJLS
AHEFC
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
FYUFA
FZ0
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PIMPY
PQQKQ
Q.N
Q11
QB0
R.K
RHX
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZA5
ZGI
ZXP
ZZTAW
~IA
~WT
24P
ALIPV
ALUQN
H13
OIG
08R
AAPBV
AAUGY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4506-ce08943a048ec64279af395d2d3ccdf4e578ffb44a58cc3131e99a274463969b3
IEDL.DBID DR2
ISSN 0001-6314
IngestDate Sat Aug 17 01:04:53 EDT 2024
Sat Sep 28 08:32:05 EDT 2024
Sun Oct 29 17:08:29 EDT 2023
Sat Aug 24 00:54:14 EDT 2024
Wed Jan 17 05:00:34 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Pathology
Flow cytometry
Neuromuscular diseases
Nervous system diseases
Myasthenia gravis
Immunocytochemistry
Ligand
T-Lymphocyte
Exploration
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4506-ce08943a048ec64279af395d2d3ccdf4e578ffb44a58cc3131e99a274463969b3
Notes ark:/67375/WNG-Q85BWR8H-2
ArticleID:ane0o098a
istex:2E779C42BCC49F926905C06EE97221948F1552D3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1034/j.1600-0404.2000.102004236.x
PMID 11071109
PQID 72397440
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_72397440
pubmed_primary_11071109
pascalfrancis_primary_1493744
wiley_primary_10_1034_j_1600_0404_2000_102004236_x_ANE102004236
istex_primary_ark_67375_WNG_Q85BWR8H_2
PublicationCentury 2000
PublicationDate October 2000
PublicationDateYYYYMMDD 2000-10-01
PublicationDate_xml – month: 10
  year: 2000
  text: October 2000
PublicationDecade 2000
PublicationPlace Copenhagen
PublicationPlace_xml – name: Copenhagen
– name: Oxford
– name: Denmark
PublicationTitle Acta neurologica Scandinavica
PublicationTitleAlternate Acta Neurol Scand
PublicationYear 2000
Publisher Munksgaard International Publishers
Blackwell
Publisher_xml – name: Munksgaard International Publishers
– name: Blackwell
SSID ssj0012744
Score 1.6641111
Snippet Objectives– To examine the expression of OX40, an activated memory T‐cell marker, and its ligand (OX40L), a set of molecules for T‐cell–B‐cell interaction, and...
To examine the expression of OX40, an activated memory T-cell marker, and its ligand (OX40L), a set of molecules for T-cell-B-cell interaction, and other...
OBJECTIVESTo examine the expression of OX40, an activated memory T-cell marker, and its ligand (OX40L), a set of molecules for T-cell-B-cell interaction, and...
SourceID proquest
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 236
SubjectTerms Adolescent
Adult
Antibodies, Monoclonal - metabolism
Antigens, CD - metabolism
Biological and medical sciences
Cerebral Cortex - metabolism
Diseases of striated muscles. Neuromuscular diseases
Female
Flow Cytometry
flowcytometry
gp34
HLA-DR Antigens - metabolism
Humans
immunocytochemistry
Ligands
Male
Medical sciences
Medulla Oblongata - metabolism
Middle Aged
myasthenia gravis
Myasthenia Gravis - genetics
Myasthenia Gravis - metabolism
Neurology
OX40
OX40 ligand
Receptors, Tumor Necrosis Factor - genetics
Receptors, Tumor Necrosis Factor - metabolism
thymus
Thymus Gland - metabolism
Thymus Gland - pathology
Title Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus
URI https://api.istex.fr/ark:/67375/WNG-Q85BWR8H-2/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1034%2Fj.1600-0404.2000.102004236.x
https://www.ncbi.nlm.nih.gov/pubmed/11071109
https://search.proquest.com/docview/72397440
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFH-adpi4AOMzY4McJgSHlDh2PnxCA3VUSC1iYlpvlj-nals6La3U8dfjZ6edhhAXuDlx7Mj-5Tm_Zz__DHBo89owY-rMcCczZgudcetMZojmChWvVAiiGU-q0Sn7Oi2nWzBZ74WJ-hCbCTe0jDBeo4FL1fXbxFk08gp3RbM8TI0EEYIQ5VENkFOith5ypJONmhRBMbzIhklWUcJ24LCv7sPfKvO0FXt8hWGTsvM95-KRF3_ipPcpbvhHHT-C-bp1MTTlYrBcqIH--Zvw4_9r_mN42NPZ9Ch-f7uwZdsnsDPuF-yfwni46iNt23Tu0m9TlqeyNTFxOTvH9Lvza8rep7M29WQ0bZFEX4aHrm5lh-IMM-1zbq-W3TM4PR7--DzK-hMcMs3KvMq0zVHfXfphwmrv6dRcOspLUxiqtXHM-vHCOcWYLButKaHEci4RJ0-cKq7oc9hu5619CSmTplacG-WU8j6paQjRJJeFto2lVNME3gaUxHVU6RDy5gKD1upSnE2-iO9N-enspBmJIoGDezBuCnhfkfo3J_BmDavwpobrJ7K182Un6sKTN8byBF5EtO-KeicapVsT-Bgwu8vAJX7K0MXyaAlECw_-xLs9WmIljibDzeXeP9fwCh4EuYAQcLgP24ubpT3wxGmhXgdz-AUxSgOw
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bT9swFD5CTGJ72dg924A8oGl7SBfHzsVPE6CybqNFQyD6ZvmKKiCtaCuV_fr5OGkR07SX7S2JY0fxl3PyHfv4M8CuTUvDjCkTw51MmM10wq0ziSGaK1S8UiGJpj8oemfs2zAfrsHxci1Mow-xGnBDywj-Gg0cB6TbdeKssfICl0WzNIyNBBWCkOZRdDypfOA9QB5irJOVnhRBObyGD5OkoIRtwG7b3qe_teaJK_b5AhMn5dT3nWs2vfgTK71PcsNf6vAJTJbv1ySnXHbmM9XRP3-TfvyPHbAJj1tGG-81n-BTWLP1M9jot3P2z6HfXbTJtnU8dvHxkKWxrE1zcDW6wOMPFxPKPsajOvZ8NK6RR1-Fm65v5RT1GUbal9xez6cv4Oywe3rQS9pNHBLN8rRItE1R4l16T2G1D3ZKLh3luckM1do4Zr3LcE4xJvNKa0oosZxLBMpzp4Ir-hLW63FtX0PMpCkV50Y5pXxYaipCNEllpm1lKdU0gvcBJjFphDqEvLnEvLUyF-eDL-JHle-fn1Q9kUWwdQ_HVQUfLlL_5Ah2lrgKb204hSJrO55PRZl5_sZYGsGrBu67qj6ORvXWCD4H0O4KcJafMoyyPFoC0cK9P_Fqi5ZYiL1Bd3X65p9b2IGHvdP-kTj6Ovj-Fh4F9YCQf_gO1mc3c7vledRMbQfb-AWjzwfS
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFD6aNqnihcu4LLBLHiYEDylJ7Fz8hAZrKZcGmJjWN8vXqdqWVmsrdfx6fJy00xDiBd6SOHZkfz7Od-zjzwCHJi401bqINLMioiZVETNWRzpRTKLilfRBNMMqH5zST6NstAHVai9Mow-xnnBDy_DjNRr4VNt2mzhtjDzHXdE09lMjXoTAR3nkXccpt2hOUuzlxydrOakE1fAaOpxEOUloBw7b8t78rTTHW7HJlxg3KWau6Wxz5sWfSOldjut_Uv0HMFlVr4lNuegu5rKrfv6m_Pj_6v8Q7rd8NjxqOuAj2DD1NnSG7Yr9Yxj2lm2obR1ObPh1RONQ1Lq5uByf4_Wr8ymhr8NxHTo2GtbIoi_9S1c3YobqDGPlUm6uFrMncNrv_Xg_iNojHCJFsziPlIlR4F24ccIo5-oUTFjCMp1qopS21LgBw1pJqchKpUhCEsOYQJwcc8qZJE9hs57UZgdCKnQhGdPSSumcUl0miUpikSpTGkIUCeClR4lPG5kOLq4vMGqtyPhZ9YF_L7N3ZyflgKcB7N2BcZ3BOYvEfTmAgxWs3NkaLqCI2kwWM16kjr1RGgfwrEH7NqvzolG7NYC3HrPbBFzjJxR9LIcWR7Tw5E982qLFl_yo6q1vn_9zCQfQ-Xbc518-Vp9fwD0vHeCDD3dhc369MHuORM3lvreMX2hnBoE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+OX40+and+OX40+ligand+%28gp34%29+in+the+normal+and+myasthenic+thymus&rft.jtitle=Acta+neurologica+Scandinavica&rft.au=Onodera%2C+J.&rft.au=Nagata%2C+T.&rft.au=Fujihara%2C+K.&rft.au=Ohuchi%2C+M.&rft.date=2000-10-01&rft.pub=Munksgaard+International+Publishers&rft.issn=0001-6314&rft.eissn=1600-0404&rft.volume=102&rft.issue=4&rft.spage=236&rft.epage=243&rft_id=info:doi/10.1034%2Fj.1600-0404.2000.102004236.x&rft.externalDBID=10.1034%252Fj.1600-0404.2000.102004236.x&rft.externalDocID=ANE102004236
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6314&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6314&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6314&client=summon